Examining downstream protein targets and pathways of Rictor-mTORC2 revealed that VTD reduces phosphorylation of Ser473 of AKT, negatively controls the population of colon cancer stem cells, slows angiogenesis, and increases both intrinsic and extrinsic apoptosis pathways. Here, RICTOR is linked to malignant colon neoplasm.